Relations between growth differentiation factor-15 and no-reflow in patients with acute myocardial infraction
Author:
Affiliation:

Department of Cardiology, Changzhou No.2 People's Hospital, Affiliated to Nanjing Medical University, Changzhou, Jiangsu 213000, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To evaluate the effect of growth differentiation factor-15 (GDF-15) in predicting no-reflow in patients with acute myocardial infraction (AMI) undergoing percutaneous coronary intervention (PCI). Methods Totally 243 consecutive patients with AMI were enrolled and serum GDF-15 levels were measured within 24 hours. All patients were divided into two groups according to the occurrence of no-reflow during PCI. Results There were 44 patients in no-reflow group (average age was 67.00±13.04 ) and 199 patients in normal-reflow group (average age was 65.54±12.98). The serum GDF-15 levels increased in no-reflow group (1073.43±364.38 ng/L vs 714.10±340.98 ng/L, P<0.001). The area under the receiver operating characteristic curves (AUC) was 0.829 (95%CI:0.766~0.892). Logistic regression showed that GDF-15 (OR:1.3,5% CI:1.001~1.004, P<0.001) and female (OR:2.6,5%CI:1.358~6.610, P=0.007) were independent risk factors for no-reflow during PCI in AMI patients. Conclusion GDF-15 and female were independent risk factors for no-reflow during PCI in AMI patients.

    Reference
    Related
    Cited by
Get Citation

SUN Ling, ZANG Xuan, ZHANG Liang-Feng, SONG Ying, CHEN Xin, LI Hai-Yan, WANG Xin, WANG Qing-Jie. Relations between growth differentiation factor-15 and no-reflow in patients with acute myocardial infraction[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2017,25(6):599-603.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 19,2017
  • Revised:May 02,2017
  • Online: June 05,2017
Article QR Code